Analytic reviews: Managing the agitated patient in the icu: Sedation, analgesia, and neuromuscular blockade

Journal of Intensive Care Medicine

Volumn 25, Issue 4, 2010, Pages 187-204

  Honiden, Shyoko ^a   Siegel, Mark D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

agitation; analgesia; critical illness; delirium; neuromuscular blockade; sedation

Indexed keywords

ALFENTANIL; AMIODARONE; DEXMEDETOMIDINE; FENTANYL; HALOPERIDOL; LORAZEPAM; MACROLIDE; MIDAZOLAM; MORPHINE; MORPHINE 6 GLUCURONIDE; NALOXONE; OLANZAPINE; PANCURONIUM; PETHIDINE; PROPOFOL; PYRROLE; QUETIAPINE; QUINOLONE; REMIFENTANIL; RISPERIDONE; SUFENTANIL; SUGAMMADEX; SUXAMETHONIUM; VECURONIUM;

AGITATION; ANALGESIA; ARTIFICIAL VENTILATION; BRADYCARDIA; BRAIN FUNCTION; BRONCHOSPASM; CLINICAL TRIAL; COGNITIVE DEFECT; CONTINUOUS INFUSION; CRITICAL ILLNESS; DELIRIUM; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISTRESS SYNDROME; DRUG COST; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; DRUG WITHDRAWAL; ENVIRONMENT; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTENSION; INTENSIVE CARE UNIT; LENGTH OF STAY; LOW DRUG DOSE; MONITORING; NEUROMUSCULAR BLOCKING; OUTCOME ASSESSMENT; PAIN; PANCREATITIS; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; SEDATION; SEPSIS; SINGLE DRUG DOSE; TREATMENT WITHDRAWAL;

ANALGESICS; CRITICAL ILLNESS; DELIRIUM; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE UNITS; PSYCHOMOTOR AGITATION; SEVERITY OF ILLNESS INDEX;

EID: 77955178798     PISSN: 08850666     EISSN: 15251489     Source Type: Journal    
DOI: 10.1177/0885066610366923     Document Type: Review

References (138)

1. Nelson JE, Meier DE, Litke A., Natale DA, Siegel RE, Morrison RS The symptom burden of chronic critical illness. Crit Care Med. 2004 ; 32 (7). 1527-1534.
2. Jaber S., Chanques G., Altairac C., et al. A prospective study of agitation in a medical-surgical ICU: incidence, risk factors, and outcomes. Chest. 2005 ; 128 (4). 2749-2757.
3. Woods JC, Mion LC, Connor JT, et al. Severe agitation among ventilated medical intensive care unit patients: frequency, characteristics and outcomes. Intensive Care Med. 2004 ; 30 (6). 1066-1072.
4. Fraser GL, Prato BS, Riker RR, Berthiaume D., Wilkins ML Frequency, severity, and treatment of agitation in young versus elderly patients in the ICU. Pharmacotherapy. 2000 ; 20 (1). 75-82.
5. Kollef MH, Levy NT, Ahrens TS, Schaiff R., Prentice D., Sherman G. The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. Chest. 1998 ; 114 (2). 541-548.
6. Kress JP, Pohlman AS, O'Connor MF, Hall JB Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl J Med. 2000 ; 342 (20). 1471-1477.
7. Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med. 2004 ; 32 (6). 1272-1276.
8. Cox CE, Reed SD, Govert JA, et al. Economic evaluation of propofol and lorazepam for critically ill patients undergoing mechanical ventilation. Crit Care Med. 2008 ; 36 (3). 706-714.
9. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008 ; 371 (9607). 126-134.
10. Jacobi J., Fraser GL, Coursin DB, et al. Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med. 2002 ; 30 (1). 119-141.
11. Rhoney DH, Murry KR National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit. J Intensive Care Med. 2003 ; 18 (3). 139-145.
12. Patel RP, Gambrell M., Speroff T., et al. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med. 2009 ; 37 (3). 825-832.
13. Afessa B., Gajic O., Keegan MT, Seferian EG, Hubmayr RD, Peters SG Impact of introducing multiple evidence-based clinical practice protocols in a medical intensive care unit: a retrospective cohort study. BMC Emerg Med. 2007 ; 7: 10.
14. Hansen-Flaschen J. Improving patient tolerance of mechanical ventilation. Challenges ahead. Crit Care Clin. 1994 ; 10 (4). 659-671.
15. Epstein J., Breslow MJ The stress response of critical illness. Crit Care Clin. 1999 ; 15 (1). 17-33, v.
16. Chanques G., Jaber S., Barbotte E., et al. Impact of systematic evaluation of pain and agitation in an intensive care unit. Crit Care Med. 2006 ; 34 (6). 1691-1699.
17. Brook AD, Ahrens TS, Schaiff R., et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med. 1999 ; 27 (12). 2609-2615.
18. Quenot JP, Ladoire S., Devoucoux F., et al. Effect of a nurse-implemented sedation protocol on the incidence of ventilator-associated pneumonia. Crit Care Med. 2007 ; 35 (9). 2031-2036.
19. Marshall J., Finn CA, Theodore AC Impact of a clinical pharmacist-enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008 ; 36 (2). 427-433.
20. Brattebo G., Hofoss D., Flaatten H., Muri AK, Gjerde S., Plsek PE Effect of a scoring system and protocol for sedation on duration of patients' need for ventilator support in a surgical intensive care unit. BMJ. 2002 ; 324 (7350). 1386-1389.
21. De Jonghe B., Bastuji-Garin S., Fangio P., et al. Sedation algorithm in critically ill patients without acute brain injury. Crit Care Med. 2005 ; 33 (1). 120-127.
22. MacLaren R., Plamondon JM, Ramsay KB, Rocker GM, Patrick WD, Hall RI A prospective evaluation of empiric versus protocol-based sedation and analgesia. Pharmacotherapy. 2000 ; 20 (6). 662-672.
23. Devlin JW, Holbrook AM, Fuller HD The effect of ICU sedation guidelines and pharmacist interventions on clinical outcomes and drug cost. Ann Pharmacother. 1997 ; 31 (6). 689-695.
24. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974 ; 2 (5920). 656-659.
25. Hansen-Flaschen J., Cowen J., Polomano RC Beyond the Ramsay scale: need for a validated measure of sedating drug efficacy in the intensive care unit. Crit Care Med. 1994 ; 22 (5). 732-733.
26. Sessler CN Sedation scales in the ICU. Chest. 2004 ; 126 (6). 1727-1730.
27. Riker RR, Picard JT, Fraser GL Prospective evaluation of the Sedation-Agitation Scale for adult critically ill patients. Crit Care Med. 1999 ; 27 (7). 1325-1329.
28. Devlin JW, Boleski G., Mlynarek M., et al. Motor Activity Assessment Scale: a valid and reliable sedation scale for use with mechanically ventilated patients in an adult surgical intensive care unit. Crit Care Med. 1999 ; 27 (7). 1271-1275.
29. de Lemos J., Tweeddale M., Chittock D. Measuring quality of sedation in adult mechanically ventilated critically ill patients: the Vancouver Interaction and Calmness Scale. Sedation Focus Group. J Clin Epidemiol. 2000 ; 53 (9). 908-919.
30. Sessler CN, Gosnell MS, Grap MJ, et al. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002 ; 166 (10). 1338-1344.
31. De Jonghe B., Cook D., Griffith L., et al. Adaptation to the Intensive Care Environment (ATICE): development and validation of a new sedation assessment instrument. Crit Care Med. 2003 ; 31 (9). 2344-2354.
32. Weinert C., McFarland L. The state of intubated ICU patients: development of a two-dimensional sedation rating scale for critically ill adults. Chest. 2004 ; 126 (6). 1883-1890.
33. Schulte-Tamburen AM, Scheier J., Briegel J., Schwender D., Peter K. Comparison of five sedation scoring systems by means of auditory evoked potentials. Intensive Care Med. 1999 ; 25 (4). 377-382.
34. Sessler CN, Jo Grap M., Ramsay MA Evaluating and monitoring analgesia and sedation in the intensive care unit. Crit Care. 2008 ; 12 (suppl 3). S2.
35. Desbiens NA, Wu AW, Broste SK, et al. Pain and satisfaction with pain control in seriously ill hospitalized adults: findings from the SUPPORT research investigations. For the SUPPORT investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments. Crit Care Med. 1996 ; 24 (12). 1953-1961.
36. Payen JF, Chanques G., Mantz J., et al. Current practices in sedation and analgesia for mechanically ventilated critically ill patients: a prospective multicenter patient-based study. Anesthesiology. 2007 ; 106 (4). 687-695 ; quiz 891-682..
37. Puntillo KA, White C., Morris AB, et al. Patients' perceptions and responses to procedural pain: results from Thunder Project II. Am J Crit Care. 2001 ; 10 (4). 238-251.
38. Hobara M. Beliefs about appropriate pain behavior: cross-cultural and sex differences between Japanese and Euro-Americans. Eur J Pain. 2005 ; 9 (4). 389-393.
39. Cleeland CS, Gonin R., Baez L., Loehrer P., Pandya KJ Pain and treatment of pain in minority patients with cancer. The Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med. 1997 ; 127 (9). 813-816.
40. Lasch KE Culture, pain, and culturally sensitive pain care. Pain Manag Nurs. 2000 ; 1 (3 suppl 1). 16-22.
41. Payen JF, Bru O., Bosson JL, et al. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med. 2001 ; 29 (12). 2258-2263.
42. Gelinas C., Johnston C. Pain assessment in the critically ill ventilated adult: validation of the Critical-Care Pain Observation Tool and physiologic indicators. Clin J Pain. 2007 ; 23 (6). 497-505.
43. Ambuel B., Hamlett KW, Marx CM, Blumer JL Assessing distress in pediatric intensive care environments: the COMFORT scale. J Pediatr Psychol. 1992 ; 17 (1). 95-109.
44. Merkel SI, Voepel-Lewis T., Shayevitz JR, Malviya S. The FLACC: a behavioral scale for scoring postoperative pain in young children. Pediatr Nurs. 1997 ; 23 (3). 293-297.
45. Odhner M., Wegman D., Freeland N., Steinmetz A., Ingersoll GL Assessing pain control in nonverbal critically ill adults. Dimens Crit Care Nurs. 2003 ; 22 (6). 260-267.
46. Young J., Siffleet J., Nikoletti S., Shaw T. Use of a Behavioural Pain Scale to assess pain in ventilated, unconscious and/or sedated patients. Intensive Crit Care Nurs. 2006 ; 22 (1). 32-39.
47. Gelinas C., Fillion L., Puntillo KA, Viens C., Fortier M. Validation of the critical-care pain observation tool in adult patients. Am J Crit Care. 2006 ; 15 (4). 420-427.
48. Rosow C., Manberg PJ Bispectral index monitoring. Anesthesiol Clin North America. 2001 ; 19 (4). 947-966, xi.
49. Schneider G., Heglmeier S., Schneider J., Tempel G., Kochs EF Patient State Index (PSI) measures depth of sedation in intensive care patients. Intensive Care Med. 2004 ; 30 (2). 213-216.
50. Cortinez LI, Delfino AE, Fuentes R., Munoz HR Performance of the cerebral state index during increasing levels of propofol anesthesia: a comparison with the bispectral index. Anesth Analg. 2007 ; 104 (3). 605-610.
51. Kreuer S., Wilhelm W., Grundmann U., Larsen R., Bruhn J. Narcotrend index versus bispectral index as electroencephalogram measures of anesthetic drug effect during propofol anesthesia. Anesth Analg. 2004 ; 98 (3). 692-697, table of contents..
52. Takamatsu I., Ozaki M., Kazama T. Entropy indices vs the bispectral index for estimating nociception during sevoflurane anaesthesia. Br J Anaesth. 2006 ; 96 (5). 620-626.
53. Struys MM, Jensen EW, Smith W., et al. Performance of the ARX-derived auditory evoked potential index as an indicator of anesthetic depth: a comparison with bispectral index and hemodynamic measures during propofol administration. Anesthesiology. 2002 ; 96 (4). 803-816.
54. Myles PS, Leslie K., McNeil J., Forbes A., Chan MT Bispectral index monitoring to prevent awareness during anaesthesia: the B-Aware randomised controlled trial. Lancet. 2004 ; 363 (9423). 1757-1763.
55. Gan TJ, Glass PS, Windsor A., et al. Bispectral index monitoring allows faster emergence and improved recovery from propofol, alfentanil, and nitrous oxide anesthesia. BIS Utility Study Group. Anesthesiology. 1997 ; 87 (4). 808-815.
56. LeBlanc JM, Dasta JF, Kane-Gill SL Role of the bispectral index in sedation monitoring in the ICU. Ann Pharmacother. 2006 ; 40 (3). 490-500.
57. Vivien B., Di Maria S., Ouattara A., Langeron O., Coriat P., Riou B. Overestimation of Bispectral Index in sedated intensive care unit patients revealed by administration of muscle relaxant. Anesthesiology. 2003 ; 99 (1). 9-17.
58. Tonner PH, Wei C., Bein B., Weiler N., Paris A., Scholz J. Comparison of two bispectral index algorithms in monitoring sedation in postoperative intensive care patients. Crit Care Med. 2005 ; 33 (3). 580-584.
59. Frenzel D., Greim CA, Sommer C., Bauerle K., Roewer N. Is the bispectral index appropriate for monitoring the sedation level of mechanically ventilated surgical ICU patients ? Intensive Care Med. 2002 ; 28 (2). 178-183.
60. Nasraway SS Jr, Wu EC, Kelleher RM, Yasuda CM, Donnelly AM How reliable is the Bispectral Index in critically ill patients? A prospective, comparative, single-blinded observer study. Crit Care Med. 2002 ; 30 (7). 1483-1487.
61. Riker RR, Fraser GL Monitoring sedation, agitation, analgesia, neuromuscular blockade, and delirium in adult ICU patients. Semin Respir Crit Care Med. 2001 ; 22 (2). 189-198.
62. Trzepacz PT Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord. 1999 ; 10 (5). 330-334.
63. van der Mast RC Pathophysiology of delirium. J Geriatr Psychiatry Neurol. 1998 ; 11 (3). 138-145 ; discussion 157-138.
64. Balas MC, Happ MB, Yang W., Chelluri L., Richmond T. Outcomes associated with delirium in older patients in surgical ICUs. Chest. 2009 ; 135 (1). 18-25.
65. Ouimet S., Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007 ; 33 (1). 66-73.
66. Lin SM, Liu CY, Wang CH, et al. The impact of delirium on the survival of mechanically ventilated patients. Crit Care Med. 2004 ; 32 (11). 2254-2259.
67. Ely EW, Gautam S., Margolin R., et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001 ; 27 (12). 1892-1900.
68. Girard TD, Pandharipande PP, Ely EW Delirium in the intensive care unit. Crit Care. 2008 ; 12 (suppl 3). S3.
69. Inouye SK, van Dyck CH, Alessi CA, Balkin S., Siegal AP, Horwitz RI Clarifying confusion: the confusion assessment method. A new method for detection of delirium. Ann Intern Med. 1990 ; 113 (12). 941-948.
70. Ely EW, Margolin R., Francis J., et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001 ; 29 (7). 1370-1379.
71. Bergeron N., Dubois MJ, Dumont M., Dial S., Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001 ; 27 (5). 859-864.
72. Plaschke K., von Haken R., Scholz M., et al. Comparison of the confusion assessment method for the intensive care unit (CAM-ICU) with the Intensive Care Delirium Screening Checklist (ICDSC) for delirium in critical care patients gives high agreement rate(s). Intensive Care Med. 2008 ; 34 (3). 431-436.
73. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001 ; 286 (21). 2703-2710.
74. Epstein SK Optimizing patient-ventilator synchrony. Semin Respir Crit Care Med. 2001 ; 22 (2). 137-152.
75. Meyer TJ, Eveloff SE, Bauer MS, Schwartz WA, Hill NS, Millman RP Adverse environmental conditions in the respiratory and medical ICU settings. Chest. 1994 ; 105 (4). 1211-1216.
76. Conrad C., Niess H., Jauch KW, Bruns CJ, Hartl W., Welker L. Overture for growth hormone: requiem for interleukin-6 ? Crit Care Med. 2007 ; 35 (12). 2709-2713.
77. Chlan L. Effectiveness of a music therapy intervention on relaxation and anxiety for patients receiving ventilatory assistance. Heart Lung. 1998 ; 27 (3). 169-176.
78. Richards KC Effect of a back massage and relaxation intervention on sleep in critically ill patients. Am J Crit Care. 1998 ; 7 (4). 288-299.
79. Coller JK, Christrup LL, Somogyi AA Role of active metabolites in the use of opioids. Eur J Clin Pharmacol. 2009 ; 65 (2). 121-139.
80. Osborne R., Joel S., Grebenik K., Trew D., Slevin M. The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clin Pharmacol Ther. 1993 ; 54 (2). 158-167.
81. Martin J., Franck M., Sigel S., Weiss M., Spies C. Changes in sedation management in German intensive care units between 2002 and 2006: a national follow-up survey. Crit Care. 2007 ; 11 (6). R124.
82. Wilhelm W., Kreuer S. The place for short-acting opioids: special emphasis on remifentanil. Crit Care. 2008 ; 12 (suppl 3). S5.
83. Bowdle TA Adverse effects of opioid agonists and agonist-antagonists in anaesthesia. Drug Saf. 1998 ; 19 (3). 173-189.
84. Weinger MB, Chen DY, Lin T., Lau C., Koob GF, Smith NT A role for CNS alpha-2 adrenergic receptors in opiate-induced muscle rigidity in the rat. Brain Res. 1995 ; 669 (1). 10-18.
85. Weinger MB, Cline EJ, Smith NT, Blasco TA, Koob GF Localization of brainstem sites which mediate alfentanil-induced muscle rigidity in the rat. Pharmacol Biochem Behav. 1988 ; 29 (3). 573-580.
86. Wandel C., Bocker R., Bohrer H., Browne A., Rugheimer E., Martin E. Midazolam is metabolized by at least three different cytochrome P450 enzymes. Br J Anaesth. 1994 ; 73 (5). 658-661.
87. Bauer TM, Ritz R., Haberthur C., et al. Prolonged sedation due to accumulation of conjugated metabolites of midazolam. Lancet. 1995 ; 346 (8968). 145-147.
88. Swart EL, van Schijndel RJ, van Loenen AC, Thijs LG Continuous infusion of lorazepam versus medazolam in patients in the intensive care unit: sedation with lorazepam is easier to manage and is more cost-effective. Crit Care Med. 1999 ; 27 (8). 1461-1465.
89. Wilson KC, Reardon C., Theodore AC, Farber HW Propylene glycol toxicity: a severe iatrogenic illness in ICU patients receiving IV benzodiazepines: a case series and prospective, observational pilot study. Chest. 2005 ; 128 (3). 1674-1681.
90. Yaucher NE, Fish JT, Smith HW, Wells JA Propylene glycol-associated renal toxicity from lorazepam infusion. Pharmacotherapy. 2003 ; 23 (9). 1094-1099.
91. Tuohy KA, Nicholson WJ, Schiffman F. Agitation by sedation. Lancet. 2003 ; 361 (9354). 308.
92. Zar T., Yusufzai I., Sullivan A., Graeber C. Acute kidney injury, hyperosmolality and metabolic acidosis associated with lorazepam. Nat Clin Pract Nephrol. 2007 ; 3 (9). 515-520.
93. Pandharipande P., Shintani A., Peterson J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006 ; 104 (1). 21-26.
94. Riker RR, Shehabi Y., Bokesch PM, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009 ; 301 (5). 489-499.
95. Barr J., Zomorodi K., Bertaccini EJ, Shafer SL, Geller E. A double-blind, randomized comparison of i.v. lorazepam versus midazolam for sedation of ICU patients via a pharmacologic model. Anesthesiology. 2001 ; 95 (2). 286-298.
96. Pohlman AS, Simpson KP, Hall JB Continuous intravenous infusions of lorazepam versus midazolam for sedation during mechanical ventilatory support: a prospective, randomized study. Crit Care Med. 1994 ; 22 (8). 1241-1247.
97. Marik PE Propofol: therapeutic indications and side-effects. Curr Pharm Des. 2004 ; 10 (29). 3639-3649.
98. Weinbroum AA, Halpern P., Rudick V., Sorkine P., Freedman M., Geller E. Midazolam versus propofol for long-term sedation in the ICU: a randomized prospective comparison. Intensive Care Med. 1997 ; 23 (12). 1258-1263.
99. Barrientos-Vega R., Mar Sanchez-Soria M., Morales-Garcia C., Robas-Gomez A., Cuena-Boy R., Ayensa-Rincon A. Prolonged sedation of critically ill patients with midazolam or propofol: impact on weaning and costs. Crit Care Med. 1997 ; 25 (1). 33-40.
100. Carson SS, Kress JP, Rodgers JE, et al. A randomized trial of intermittent lorazepam versus propofol with daily interruption in mechanically ventilated patients. Crit Care Med. 2006 ; 34 (5). 1326-1332.
101. Weber RJ, Kane SL, Oriolo VA, Saul M., Skledar SJ, Dasta JF Impact of intensive care unit (ICU) drug use on hospital costs: a descriptive analysis, with recommendations for optimizing ICU pharmacotherapy. Crit Care Med. 2003 ; 31 (1 suppl). S17 - S24.
102. Shao X., Li H., White PF, Klein KW, Kulstad C., Owens A. Bisulfite-containing propofol: is it a cost-effective alternative to Diprivan for induction of anesthesia ? Anesth Analg. 2000 ; 91 (4). 871-875.
103. Baker GJ, Collett P., Allen DH Bronchospasm induced by metabisulphite-containing foods and drugs. Med J Aust. 1981 ; 2 (11). 614-617.
104. Gunnison AF, Jacobsen DW Sulfite hypersensitivity. A critical review. CRC Crit Rev Toxicol. 1987 ; 17 (3). 185-214.
105. Sabbah A., Drouet M., Bonneau JC, Le Sellin J. [Reactions to metabisulfites in aspirin-induced asthma]. Allerg Immunol (Paris). 1987 ; 19 (1). 25-28.
106. Sanz J., Martorell A., Torro I., Carlos Cerda J., Alvarez V. Intolerance to sodium metabisulfite in children with steroid-dependent asthma. J Investig Allergol Clin Immunol. 1992 ; 2 (1). 36-38.
107. Stevenson DD, Simon RA Sensitivity to ingested metabisulfites in asthmatic subjects. J Allergy Clin Immunol. 1981 ; 68 (1). 26-32.
108. Henry B., Plante-Jenkins C., Ostrowska K. An outbreak of Serratia marcescens associated with the anesthetic agent propofol. Am J Infect Control. 2001 ; 29 (5). 312-315.
109. Vasile B., Rasulo F., Candiani A., Latronico N. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intensive Care Med. 2003 ; 29 (9). 1417-1425.
110. Gerlach AT, Dasta JF Dexmedetomidine: an updated review. Ann Pharmacother. 2007 ; 41 (2). 245-252.
111. Pandharipande PP, Pun BT, Herr DL, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007 ; 298 (22). 2644-2653.
112. Tandon R. Safety and tolerability: how do newer generation "atypical" antipsychotics compare ? Psychiatr Q. 2002 ; 73 (4). 297-311.
113. Sharma ND, Rosman HS, Padhi ID, Tisdale JE Torsades de Pointes associated with intravenous haloperidol in critically ill patients. Am J Cardiol. 1998 ; 81 (2). 238-240.
114. O'Brien JM, Rockwood RP, Suh KI Haloperidol-induced torsade de pointes. Ann Pharmacother. 1999 ; 33 (10). 1046-1050.
115. Seitz DP, Gill SS, van Zyl LT Antipsychotics in the treatment of delirium: a systematic review. J Clin Psychiatry. 2007 ; 68 (1). 11-21.
116. Han CS, Kim YK A double-blind trial of risperidone and haloperidol for the treatment of delirium. Psychosomatics. 2004 ; 45 (4). 297-301.
117. Skrobik YK, Bergeron N., Dumont M., Gottfried SB Olanzapine vs haloperidol: treating delirium in a critical care setting. Intensive Care Med. 2004 ; 30 (3). 444-449.
118. Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999 ; 340 (9). 669-676.
119. Marcantonio ER, Flacker JM, Wright RJ, Resnick NM Reducing delirium after hip fracture: a randomized trial. J Am Geriatr Soc. 2001 ; 49 (5). 516-522.
120. Lundstrom M., Edlund A., Karlsson S., Brannstrom B., Bucht G., Gustafson Y. A multifactorial intervention program reduces the duration of delirium, length of hospitalization, and mortality in delirious patients. J Am Geriatr Soc. 2005 ; 53 (4). 622-628.
121. Siegel MD "Wake up and breathe" for patients with respiratory failure. Lancet. 2008 ; 371 (9622). 1414 ; author reply 1414-1415.
122. Erstad BL, Puntillo K., Gilbert HC, et al. Pain management principles in the critically ill. Chest. 2009 ; 135 (4). 1075-1086.
123. de Wit M., Gennings C., Jenvey WI, Epstein SK Randomized trial comparing daily interruption of sedation and nursing-implemented sedation algorithm in medical intensive care unit patients. Crit Care. 2008 ; 12 (3). R70.
124. Cheng IW, Eisner MD, Thompson BT, Ware LB, Matthay MA Acute effects of tidal volume strategy on hemodynamics, fluid balance, and sedation in acute lung injury. Crit Care Med. 2005 ; 33 (1). 63-70 ; discussion 239-240.
125. Yentis SM Suxamethonium and hyperkalaemia. Anaesth Intensive Care. 1990 ; 18 (1). 92-101.
126. Thapa S., Brull SJ Succinylcholine-induced hyperkalemia in patients with renal failure: an old question revisited. Anesth Analg. 2000 ; 91 (1). 237-241.
127. Murray MJ, Cowen J., DeBlock H., et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2002 ; 30 (1). 142-156.
128. Murray MJ, Coursin DB, Scuderi PE, et al. Double-blind, randomized, multicenter study of doxacurium vs. pancuronium in intensive care unit patients who require neuromuscular-blocking agents. Crit Care Med. 1995 ; 23 (3). 450-458.
129. Rudis MI, Sikora CA, Angus E., et al. A prospective, randomized, controlled evaluation of peripheral nerve stimulation versus standard clinical dosing of neuromuscular blocking agents in critically ill patients. Crit Care Med. 1997 ; 25 (4). 575-583.
130. Lenart SB, Garrity JA Eye care for patients receiving neuromuscular blocking agents or propofol during mechanical ventilation. Am J Crit Care. 2000 ; 9 (3). 188-191.
131. Caldwell JE, Miller RD Clinical implications of sugammadex. Anaesthesia. 2009 ; 64 (suppl 1). 66-72.
132. Ely EW, Truman B., Shintani A. et al. Monitoring sedation status over time in ICU patients: reliability and validity of the Richmond Agitation-Sedation Scale (RASS). JAMA 2003 ; 289: 2983-2991.
133. Riker RR, Fraser GL, Cox PM Continuous infusion of haloperidol controls agitation in critically ill patients. Crit Care Med 1994 ; 22 (3). 433-440.
134. Brandl KM, Langley KA, Riker RR et al. Confirming the reliability of the sedation-agitation scale administered by ICU nurses without experience in its use. Pharmacotherapy 2001 ; 21: 431-436.
135. Clemmer TP, Wallace JC, Spuhler VJ et al. Origins of the motor activity assessment scale score: a multi-institutional process. Crit Care Med 2000 ; 28 (8). 3124.
136. Hogg LH, Bobek MB, Mion LC et al. Interrater reliability of 2 sedation scales in a medical intensive care unit: a preliminary report. Am J Crit Care 2001 ; 10 (2). 79-83.
137. Pun BT, Gordon SM, Peterson JF et al. Large-scale implementation of sedation and delirium monitering in the intensive care unit: a report from two medical centers. Crit Care Med 2005 ; 33: 1199-1205.
138. Siegel MD Management of Agitation in the Intensive Care Unit. Clin Chest Med. 2003 ; 24 (4). 713-725.